IP Library Granted Patent US 9,526,920
Granted Patent B2
US 9,526,920 · App. 13/271,870 · Granted Dec 27, 2016

Medical device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,526,920
App. No.
13/271,870
Granted
Dec 27, 2016
Kind
B2
Abstract

A medical device includes a treatment module configured to apply a treatment to a patient. The medical device includes an interface configured to operatively connect to a removable storage device storing authorization data that identifies a level of treatment authorization. The medical device includes a processing device configured to perform operations in response to receiving user input indicating a treatment should be initiated. The operations include determining whether the removable storage device is valid for use with the medical device. If the removable storage device is determined to be valid, the authorization data is accessed. The processing device determines whether the treatment is authorized based on the accessed authorization data. If the treatment is determined to be authorized, the treatment module is controlled to apply the treatment. If the treatment is determined to not be authorized, the treatment module is controlled such that the treatment is not applied.

Claims (78)

1. A medical device comprising:

at least one treatment source configured to couple to damaged tissue and apply therapy to the damaged tissue to stimulate healing;

a memory device configured to store authorization data, the authorization data being usable to determine that a patient is authorized to use the at least one treatment source in a first geographic area and unauthorized to use the at least one treatment source in a second geographic area;

a communication module configured to receive an update to the authorization data via a communication network, the update being usable to determine that the patient is authorized to use the at least one treatment source in the second geographic area; and

at least one processing device configured to:

prior to receiving the update with the communication module,

determine from the authorization data that the patient is authorized to use the at least one treatment source in the first geographic area and unauthorized to use the at least one treatment source in the second geographic area,

receive a first user input indicating to initiate therapy with the at least one treatment source,

determine a first location of the at least one treatment source in response to receiving the first user input,

permit application of therapy by the at least one treatment source in response to determining that the patient is authorized to use the at least one treatment source and that the first location is in the first geographic area,

receive a second user input indicating to initiate therapy with the at least one treatment source,

determine a second location of the at least one treatment source in response to receiving the second user input, and

prevent application of therapy by the at least one treatment source in response to determining that the second location is in the second geographic area, receive the update with the communication module, and

subsequent to receiving the update with the communication module,

determine from the authorization data and the update that the patient is authorized to use the at least one treatment source in the second geographic area,

receive a third user input indicating to initiate therapy with the at least one treatment source,

determine a third location of the at least one treatment source in response to receiving the third user input, and

permit application of therapy by the at least one treatment source in response to determining that the patient is authorized to use the at least one treatment source and that the third location is in the second geographic area.

2. The medical device of claim 1 , wherein the communication network is a wireless communication network.

3. The medical device of claim 2 , wherein the wireless communication network is a cellular wireless communication network.

4. The medical device of claim 1 , wherein:

the memory device stores a device identifier;

the authorization data is encrypted; and

the at least one processing device is further configured to decrypt the authorization data using the device identifier.

5. The medical device of claim 1 , further comprising a sensor configured to receive a first authentication input from the patient, wherein:

the at least one processing device is configured to:

prior to receiving the update with the communication module,

determine from the first authentication input that the patient is using the at least one treatment source, and

permit application of therapy by the at least one treatment source in response to determining that (i) the patient is authorized to use the at least one treatment source, (ii) that the first location is in the first geographic area, and (iii) the patient is using the at least one treatment source, and

subsequent to receiving the update with the communication module,

determine from the first authentication input that the patient is using the at least one treatment source, and

permit application of therapy by the at least one treatment source in response to determining that (i) the patient is authorized to use the at least one treatment source, (ii) that the third location is in the second geographic area, and (iii) the patient is using the at least one treatment source.

6. The medical device of claim 5 , wherein the first authentication input comprises a fingerprint image.

7. The medical device of claim 5 , wherein the first authentication input comprises a retinal image.

8. The medical device of claim 5 , wherein the first authentication input comprises a voice recording.

9. The medical device of claim 5 , wherein:

the sensor is configured to receive a second authentication input from an individual other than the patient; and

the at least one processing device is configured to:

prior to receiving the update with the communication module,

determine from the second authentication input that the patient is attended to by the individual while using the at least one treatment source, and

permit application of therapy by the at least one treatment source in response to determining that (i) the patient is authorized to use the at least one treatment source, (ii) that the first location is in the first geographic area, (iii) the patient is using the at least one treatment source, and (iv) the patient is attended to by the individual while using the at least one treatment source, and

subsequent to receiving the update with the communication module,

determine from the second authentication input that the patient is attended to by the individual while using the at least one treatment source, and

permit application of therapy by the at least one treatment source in response to determining that (i) the patient is authorized to use the at least one treatment source, (ii) that the third location is in the second geographic area, (iii) the patient is using the at least one treatment source, and (iv) the patient is attended to by the individual while using the at least one treatment source.

10. The medical device of claim 1 , further comprising an alarm indicator, wherein:

the at least one processing device is configured to:

prior to receiving the update with the communication module,

activate the alarm indicator in response to determining that the second location is in the second geographic area.

11. The medical device of claim 1 , wherein:

the at least one treatment source comprises a driver circuit configured to control application of therapy to the damaged issue; and

the at least one processing device is configured to permit application of therapy by activating the driver circuit.

12. The medical device of claim 1 , wherein:

the at least one treatment source comprises a driver circuit configured to control application of therapy to the damaged issue; and

the at least one processing device is configured to permit application of therapy by not deactivating the driver circuit.

13. The medical device of claim 1 , wherein:

the at least one treatment source comprises a driver circuit configured to control application of therapy to the damaged issue; and

the at least one processing device is configured to prevent application of therapy by not activating the driver circuit.

14. The medical device of claim 1 , wherein:

the at least one treatment source comprises a driver circuit configured to control application of therapy to the damaged issue; and

the at least one processing device is configured to prevent application of therapy by deactivating the driver circuit.

15. The medical device of claim 1 , wherein:

the at least one treatment source comprises a driver circuit configured to control application of therapy to the damaged issue; and

the at least one processing device is configured to prevent application of therapy by setting an output of the driver circuit.

16. The medical device of claim 1 , wherein the communication module is configured to receive the update via the communication network from a server system.

17. The medical device of claim 1 , further comprising a GPS receiver configured to determine a geographical location of the at least one treatment source, and the at least one processing device is configured to determine the first location from the GPS receiver.

18. The medical device of claim 1 , further comprising a user interface configured to receive the first user input, the second user input, and the third user input as selections of at least one element of the user interface.

19. A computer-implemented method comprising:

determining from authorization data that a patient is authorized to use at least one treatment source of a medical device in a first geographic area, the authorization data being accessed from a memory device of the medical device and usable to determine that the patient is authorized to use the at least one treatment source in the first geographic area and unauthorized to use the at least one treatment source in a second geographic area, the at least one treatment source being configured to couple to damaged tissue of the patient;

receiving a first user input indicating to initiate therapy with the at least one treatment source;

determining a first location of the at least one treatment source in response to receiving the first user input;

performing therapy to the damaged issue to stimulate healing in response to determining that the patient is authorized to use the at least one treatment source and that the first location is in the first geographic area;

receiving an update to the authorization data via a communication network, the update being usable to determine that the patient is authorized to use the at least one treatment source in the second geographic area;

determining from the authorization data and the update that the patient is authorized to use the at least one treatment source in the second geographic area;

receiving a second user input indicating to initiate therapy with the at least one treatment source;

determining a second location of the at least one treatment source in response to receiving the second user input; and

performing therapy to the damaged issue to stimulate healing in response to determining that the patient is authorized to use the at least one treatment source and that the second location is in the second geographic area.

20. The computer-implemented method of claim 19 , wherein the communication network is a wireless communication network.

21. The computer-implemented method of claim 20 , wherein the wireless communication network is a cellular wireless communication network.

Assignments (12)
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 6, 2016
From: JPMORGAN CHASE BANK, N.A.
To: BIOVENTUS LLC
Reel/Frame 040827/0835 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 6, 2016
From: CITIZENS BANK, N.A.
To: BIOVENTUS LLC
Reel/Frame 040827/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2016
From: TANIS, KEVIN J.; ZHANG, JIN; ARRINGTON, DEBRA ANN; UMSTEAD, KELLY ANN
To: SMITH & NEPHEW, INC.
Reel/Frame 039589/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2016
From: BIOVENTUS, LLC
To: SMITH & NEPHEW, INC.
Reel/Frame 038925/0708 →
SECURITY INTEREST Recorded Oct 20, 2014
From: BIOVENTUS LLC
To: CITIZENS BANK, N.A.
Reel/Frame 033980/0696 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2014
From: SMITH & NEPHEW, INC.
To: BIOVENTUS LLC
Reel/Frame 033934/0153 →
SECURITY INTEREST Recorded Oct 12, 2014
From: BIOVENTUS LLC
To: JPMORGAN CHASE BANK, N.A
Reel/Frame 033934/0137 →
RELEASE OF SECURITY INTEREST Recorded Oct 10, 2014
From: HSBC BANK USA, NATIONAL ASSOCIATION
To: BIOVENTUS LLC; EXOGEN, INC.
Reel/Frame 033931/0581 →
SECURITY AGREEMENT Recorded Jun 12, 2013
From: BIOVENTUS LLC; EXOGEN, INC.
To: HSBC BANK USA, NATIONAL ASSOCIATION
Reel/Frame 030601/0824 →
ASSIGNMENT OF SECURITY AGREEMENT Recorded May 9, 2012
From: SMITH & NEPHEW HOLDINGS, INC.
To: SMITH & NEPHEW, INC.
Reel/Frame 028185/0127 →
SECURITY AGREEMENT Recorded May 8, 2012
From: BIOVENTUS LLC
To: SMITH & NEPHEW HOLDINGS, INC.
Reel/Frame 028177/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2012
From: SMITH & NEPHEW, INC.; SMITH & NEPHEW PLC
To: BIOVENTUS LLC
Reel/Frame 028167/0491 →